Company intelligence / Profile preview
Cylene Pharmaceuticals
San Diego, California, United States
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Cylene Pharmaceuticals was a San Diego-based biotech company focused on developing targeted small-molecule drugs for life-threatening cancers, especially those resistant to existing therapies. Its lead technology involved inhibiting ribosomal RNA biosynthesis and targeting G quadruplex DNA structures. The most advanced candidate, CX‑3543, reached late Phase I trials for cancer but the company appears to have ceased operations with all pipeline programs either discontinued or inactive as of the latest records.
- Therapeutic areas
- HematologyOncology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Cylene Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cylene Pharmaceuticals.